Supplementary Figure S4 from Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Bruna Pellini; Russell William Madison; Merrida A. Childress; Shoshana T. Miller; Ole V. Gjoerup; Jason Cheng; Richard S.P. Huang; Michael R. Krainock; Pratyush Gupta; Wei Zou; David S. Shames; Solomon Moshkevich; Marcus Ballinger; MC Liu; Amanda G. Young; Minu K. Srivastava; Geoffrey R. Oxnard; Mark A. Socinski

doi:10.1158/1078-0432.31085011

Supplementary Figure S4 from Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

2026 Open access

Read full text

Authors: Bruna Pellini, Russell William Madison, Merrida A. Childress, Shoshana T. Miller, Ole V. Gjoerup, Jason Cheng, Richard S.P. Huang, Michael R. Krainock, Pratyush Gupta, Wei Zou, David S. Shames, Solomon Moshkevich

+6 more

Marcus Ballinger, MC Liu, Amanda G. Young, Minu K. Srivastava, Geoffrey R. Oxnard, Mark A. Socinski

DOI: 10.1158/1078-0432.31085011

Cited by: 0

Abstract

Supplementary Figure S4: Full clearance of ctDNA at C4D1 on chemoIO identifies patients with poorer outcomes on IO maintenance, independent of PD-L1 status

Fields of Study & Subjects

Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

Publication details

Publication date: 19 January 2026